Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00113178
Status:
COMPLETED
Last Update Posted:
2011-02-24
First Post:
2005-06-06
Brief Title:
Safety and Efficacy of the CryoCor Cardiac Cryoablation System for the Treatment of Atrial Flutter
Sponsor:
Boston Scientific Corporation
Organization:
Boston Scientific Corporation
Study Overview
Official Title:
Clinical Study to Evaluate the Safety and Efficacy of the CryoCor Cardiac Cryoablation System for the Treatment of Cavo-Tricuspid Valve Isthmus-Dependent Atrial Flutter
Status:
COMPLETED
Status Verified Date:
2011-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the safety and efficacy of right atrial intra-cardiac lesions created by transvenous catheter cryoablation in patients with atrial flutter
Detailed Description:
Catheter ablation of arrhythmias has become an accepted alternative to pharmacologic therapy Cryoablation is a newer alternative to radiofrequency ablations This study expands the prior pilot experience with the CryoCor Cardiac Cryoablation System to a larger cohort of patients with atrial flutter
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None